ICU Medical, Inc.
Financials
Valuation Metrics
ICU Medical, Inc.'s Market Cap is $4.06B. At end of 2025 it was $3.52B. Ranked #1469 of 3,116 in US market (top 47%), #506 of 1,472 on NASDAQ (top 34%), #95 of 203 in Health Care Equipment & Services (top 47%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.06B | US#1,469/3,116 Sec#95/203 |
| Revenue | $2.16B | US#1,375/3,116 Sec#88/203 |
| Net Income | $30M | US#2,018/3,116 Sec#102/203 |
| Total Assets | $3.97B | US#1,596/3,116 Sec#75/203 |
| Net Assets | $2.15B | US#1,184/3,116 Sec#60/203 |
| Employees | 13,000 | US#742/3,116 Sec#57/203 |
| Value | ||
| P/E | 135.03x | US#2,138/3,116 Sec#112/203 |
| P/B | 1.89x | US#1,231/3,116 Sec#53/203 |
| P/S | 1.88x | US#1,254/3,116 Sec#84/203 |
| EV/EBITDA | 16.92x | US#1,734/3,116 Sec#75/203 |
| FCF Yield | 3.76% | US#1,672/3,116 Sec#88/203 |
| Profitability | ||
| ROE | 1.40% | US#2,046/3,116 Sec#110/203 |
| ROA | 0.76% | US#2,062/3,116 Sec#117/203 |
| Op. Margin | 5.04% | US#1,955/3,116 Sec#105/203 |
| Revenue Growth | -8.98% | US#2,538/3,116 Sec#191/203 |
| Financial Health | ||
| Debt Ratio | 84.55% | US#935/3,116 Sec#94/203 |
| Total Debt | $1.27B | US#1,390/3,116 Sec#75/203 |
| FCF | $153M | US#1,530/3,116 Sec#89/203 |
| Cash | $298M | US#1,417/3,116 Sec#81/203 |
| Current Ratio | 2.43x | US#998/3,116 Sec#98/203 |
| Net Debt/EBITDA | 3.27x | US#1,692/3,116 Sec#105/203 |
| Performance | ||
| 1Y Return | 35.37% | US#618/3,116 Sec#62/203 |
| 1M Return | 2.00% | US#1,498/3,116 Sec#138/203 |
| From 52W High | -15.71% | US#1,056/3,116 Sec#95/203 |
| 1Y MDD | -27.18% | US#1,097/3,116 Sec#42/203 |
| Trading | ||
| Volume | 211,138 shares | US#2,750/3,116 Sec#186/203 |
| Trading Value | $35M | US#1,729/3,116 Sec#123/203 |
| Per Share | ||
| EPS | $1.20 | US#1,608/3,116 Sec#86/203 |
| BPS | $86.10 | US#156/3,116 Sec#12/203 |
Company Info
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.